Eversense Continuous Glucose Monitoring System
FDA premarket approval P160048/S013 · decided 2019-08-29
Approval details
- PMA number
- P160048
- Supplement
- S013
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Eversense Continuous Glucose Monitoring System
- Generic name
- Sensor, glucose, implanted, non-adjunctive use
- Applicant
- Senseonics, Incorporated
- Date received
- 2019-07-31
- Decision date
- 2019-08-29
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- QHJ
- Advisory committee
- Clinical Chemistry
- Expedited review
- No
- Location
- Germantown, MD
- Statement
- New manufacturing site for the electronics assembly and encasement process for the sensor component of the Eversense continuous glucose monitoring system.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Eversense 365 Continuous Glucose Monitoring (CGM) System (K241335) | Senseonics, Incorporated | 2024-09-16 |
| Eversense AP CGM System (DEN230052) | Senseonics, Incorporated | 2024-04-29 |